Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
Prognostic stratification in patients with myelodysplastic syndrome (MDS) relies on a number of key factors. Combining such patient-related and disease-related prognostic parameters into useful assessment tools remains a challenge. The most widely used scoring systems include the international progn...
Main Authors: | Gattermann, N. (Author), Germing, U. (Author), Kasprzak, A. (Author), Nachtkamp, K. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01) -
Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes
by: Vincent Jachiet, et al.
Published: (2021-05-01) -
Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?
by: Annika Kasprzak, et al.
Published: (2021-07-01) -
AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.
by: Pasquale Niscola
Published: (2014-02-01) -
Cytogenetic studies of Brazilian pediatric myelodysplastic syndrome cases: challenges and difficulties in a large and emerging country
by: E.D.R.P. Velloso, et al.
Published: (2013-01-01)